Ito K, Nagata K, Ohta S, Matsuda Y, Ukai T, Yasuda I, Ota A, Kobayashi R, Kabata M, Sankoda N, et al. The oncogene-dependent resistance to reprogramming unveils cancer therapeutic targets. Cell Rep. 2022;39(4):110721. Google ScholarPubMedLog in or register to post comments